Microsatellite instability and mismatch repair protein deficiency: equal predictive markers?
Current clinical guidelines recommend mismatch repair (MMR) protein immunohistochemistry (IHC) or molecular microsatellite instability (MSI) tests as predictive markers of immunotherapies. Most of the pathological guidelines consider MMR protein IHC as the gold standard test to identify cancers with...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2024-04-01
|
| Seri Bilgileri: | Pathology and Oncology Research |
| Konular: | |
| Online Erişim: | https://www.por-journal.com/articles/10.3389/pore.2024.1611719/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|